WT1 and Duchenne muscular dystrophy: We summarized in Fig. 8 the averages of the data from DMD patients (ΔDMD) and we observed a range of 72–87% of the 37–42 probe localized into DMD nuclei in all sample types, myoblasts, myotubes, and skeletal muscles, while WT1 and WT2 showed a clear predominant cytoplasm localization (range 55–76%).